About
Corbus Pharmaceuticals Holdings, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 5 2026
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026
Apr 22 2026
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
Apr 14 2026
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Apr 7 2026
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Mar 18 2026
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
Recent Videos

Corbus CEO Yuval Cohen: Upcoming Catalysts, CRB-701 Oncology and CRB-913 Obesity Clinical Trial Data
Apr 19, 2026

How to Buy Shares of Corbus Pharmaceuticals Holding (CRBP)
Apr 13, 2026

CRBP STOCK : MOMENTUM IS BUILDING | CORBUS PHARMACEUTICALS HOLDINGS STOCK
Apr 13, 2026

07 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 07, 2026
Translate